Shares of Avantor, Inc. (NYSE:AVTR – Get Free Report) have received a consensus rating of “Hold” from the fifteen analysts that are covering the stock, Marketbeat Ratings reports. Eight research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $15.50.
A number of research analysts have weighed in on AVTR shares. Morgan Stanley cut their price objective on shares of Avantor from $15.00 to $12.00 and set an “equal weight” rating for the company in a report on Monday, August 4th. Wells Fargo & Company cut their price target on Avantor from $19.00 to $16.00 and set an “overweight” rating for the company in a research note on Monday, August 4th. Stifel Nicolaus set a $12.00 price target on Avantor and gave the stock a “hold” rating in a report on Monday, August 4th. JPMorgan Chase & Co. lowered their price target on Avantor from $17.00 to $14.00 and set an “overweight” rating on the stock in a research report on Monday, August 4th. Finally, Raymond James Financial set a $14.00 price objective on Avantor and gave the company an “outperform” rating in a research report on Monday, August 4th.
Get Our Latest Research Report on AVTR
Insider Buying and Selling
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of AVTR. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Avantor by 10.5% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 6,257 shares of the company’s stock valued at $132,000 after acquiring an additional 592 shares during the last quarter. Tidal Investments LLC boosted its stake in shares of Avantor by 59.6% in the fourth quarter. Tidal Investments LLC now owns 18,869 shares of the company’s stock worth $398,000 after acquiring an additional 7,048 shares during the last quarter. Toronto Dominion Bank increased its position in shares of Avantor by 6.9% during the fourth quarter. Toronto Dominion Bank now owns 88,812 shares of the company’s stock worth $1,871,000 after purchasing an additional 5,748 shares in the last quarter. Mackenzie Financial Corp raised its stake in Avantor by 33.0% in the 4th quarter. Mackenzie Financial Corp now owns 43,358 shares of the company’s stock valued at $914,000 after purchasing an additional 10,764 shares during the last quarter. Finally, Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Avantor in the 4th quarter valued at $5,712,000. 95.08% of the stock is owned by hedge funds and other institutional investors.
Avantor Stock Up 9.7%
Avantor stock opened at $13.69 on Friday. The business’s 50-day moving average price is $12.76 and its 200 day moving average price is $13.57. The company has a quick ratio of 0.67, a current ratio of 0.98 and a debt-to-equity ratio of 0.48. The firm has a market cap of $9.33 billion, a price-to-earnings ratio of 13.82, a price-to-earnings-growth ratio of 4.02 and a beta of 0.98. Avantor has a 52 week low of $10.82 and a 52 week high of $26.14.
Avantor (NYSE:AVTR – Get Free Report) last released its quarterly earnings data on Friday, August 1st. The company reported $0.24 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.01). The company had revenue of $1.68 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Avantor had a return on equity of 11.39% and a net margin of 10.31%.The company’s revenue for the quarter was down 1.1% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.25 EPS. As a group, sell-side analysts anticipate that Avantor will post 1.06 earnings per share for the current year.
About Avantor
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Recommended Stories
- Five stocks we like better than Avantor
- Breakout Stocks: What They Are and How to Identify Them
- Datavault AI: The New AI Contender Backed by Big Funding
- Insider Trading – What You Need to Know
- CoreWeave: Why the New King of AI Infrastructure Has Room to Run
- How to Calculate Inflation Rate
- Top 3 Dividend Achievers for October: High Yields, Growth Ahead
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.